- Design
- Single-centre randomised controlled trial
- Population
- 149 men having robot-assisted radical prostatectomy (75 opioid-free, 74 opioid-based)
- Primary outcome
- Cumulative 24-hour oxycodone patient-controlled analgesia consumption
- Effect
- Median 12.0 vs 19.0 mg (p = 0.001); Hodges-Lehmann difference -6.0 mg (95% CI -10.0 to -2.0)
This single-centre randomised trial allocated 149 men having robot-assisted radical prostatectomy 1:1 to opioid-free anaesthesia (dexmedetomidine plus ketamine, no intraoperative opioids) or a remifentanil-based technique. Both groups had the same premedication, bilateral quadratus lumborum block, sevoflurane and oxycodone patient-controlled analgesia.
Cumulative 24-hour oxycodone use was lower with the opioid-free technique (median 12.0 mg, IQR 6.0 to 22.0) than with remifentanil (19.0 mg, 10.5 to 34.0; p = 0.001), a Hodges-Lehmann difference of -6.0 mg (95% CI -10.0 to -2.0). Pain scores did not differ at any time, nausea and vomiting were infrequent and similar, and intraoperative haemodynamic events, white cell count and creatinine were similar.
A 6 mg median difference is modest, and it was achieved on top of a regional block. It is a single-centre trial and the abstract does not say who was blinded, so the finding supports a conversation with the anaesthesia team, not a unit-wide change.
- 24-hour oxycodone use was lower with opioid-free anaesthesia (median 12.0 vs 19.0 mg, p = 0.001).
- Pain scores did not differ at any time point.
- Haemodynamic events, nausea and creatinine were similar.
- Both groups had a quadratus lumborum block, so results may not apply without regional analgesia.
- Discuss with your anaesthetic team; single-centre evidence.
Why it matters
Reducing opioids after prostatectomy is a stated goal in enhanced recovery pathways.
Don't overread it
The primary outcome was a drug-use measure, not recovery or long-term pain, and the trial was at a single centre.
The statistics, in plain English
A difference of 6 mg in median oxycodone is statistically clear, but whether it matters to patients depends on side effects and recovery, which were not clearly different. The confidence interval of -10 to -2 mg indicates the true saving could be small.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free